Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study

Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study

Abstract Introduction Inconvenient administration and side effects of some disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) can deter adherence. We evaluated treatment satisfaction with cladribine tablets (CladT) for RMS in the Arabian Gulf. Methods This was a non-interventi...

Full description

Bibliographic Details
Main Authors: Jihad Inshasi, Samar Farouk, Ahmed Shatila, Ali Hassan, Miklos Szolics, Mona Thakre, Deeb Kayed, Derk Krieger, Abubaker Almadani, Taoufik Alsaadi, Beatrice Benedetti, Victoria Mifsud, Anu Jacob, Shatha Sayegh, Amir Boshra, Raed Alroughani
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-06-01
Series:Neurology and Therapy
Subjects:
Multiple sclerosis
Cladribine tablets
Patient-reported outcomes
Disease-modifying therapy
Online Access:https://doi.org/10.1007/s40120-023-00497-2

Internet

https://doi.org/10.1007/s40120-023-00497-2

Similar Items